‘All-clear’ cancer referral patients at higher risk of subsequent cancer
Over 63,000 cancer cases were diagnosed between one and five years after referral
Read More
Tag: urgent suspected cancer pathways
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
